Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer
Sandro Mascena Gomes-Filho, Edmilson Ozorio dos Santos, Ester Risério Matos Bertoldi, Luiza Coimbra Scalabrini, Vitor Heidrich, Bianca Dazzani, Elena Levantini, Eduardo M. Reis, Daniela S. Daniela Sanchez Bassères
Topics & Concepts
KRASCancer researchClonogenic assayPancreatic cancerMedicineCancerBiologyOncologyInternal medicineCellColorectal cancerGeneticsMicrotubule and mitosis dynamicsPancreatic and Hepatic Oncology ResearchCancer-related Molecular Pathways